BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31175699)

  • 1. Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers.
    Aikawa A; Fujita H; Kosaka T; Minato H; Kiyokawa E
    Cancer Sci; 2019 Aug; 110(8):2667-2675. PubMed ID: 31175699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of CD133 and ezrin expression in colorectal carcinoma.
    Fathi A; Mosaad H; Hussein S; Roshdy M; Ismail EI
    IUBMB Life; 2017 May; 69(5):328-340. PubMed ID: 28261953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?
    Archilla I; Díaz-Mercedes S; Aguirre JJ; Tarragona J; Machado I; Rodrigo MT; Lopez-Prades S; Gorostiaga I; Landolfi S; Alén BO; Balaguer F; Castells A; Camps J; Cuatrecasas M
    Clin Transl Gastroenterol; 2021 Mar; 12(3):e00303. PubMed ID: 33939382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma.
    Reggiani Bonetti L; Lionti S; Vitarelli E; Barresi V
    Virchows Arch; 2017 Dec; 471(6):731-741. PubMed ID: 28819729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathological significance of micropapillary pattern in colorectal cancers.
    Pyo JS; Park MJ; Kang DW
    Hum Pathol; 2018 Jul; 77():159-165. PubMed ID: 29634975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of poorly differentiated clusters predicts survival in stage II colorectal cancer.
    Ammendola S; Turri G; Marconi I; Burato G; Pecori S; Tomezzoli A; Conti C; Pedrazzani C; Barresi V
    Virchows Arch; 2021 Feb; 478(2):241-248. PubMed ID: 32577812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High level of ezrin expression in colorectal cancer tissues is closely related to tumor malignancy.
    Wang HJ; Zhu JS; Zhang Q; Sun Q; Guo H
    World J Gastroenterol; 2009 Apr; 15(16):2016-9. PubMed ID: 19399936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters.
    Lionti S; Reggiani Bonetti L; Bettelli S; Spallanzani A; Gelsomino F; Barresi V
    Hum Pathol; 2018 Aug; 78():115-124. PubMed ID: 29715463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.
    Ghaffari A; Hoskin V; Turashvili G; Varma S; Mewburn J; Mullins G; Greer PA; Kiefer F; Day AG; Madarnas Y; SenGupta S; Elliott BE
    Breast Cancer Res; 2019 Jan; 21(1):12. PubMed ID: 30678714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Poorly Differentiated Clusters in Liver Metastatic Lesions of Colorectal Carcinoma.
    Yonemura K; Kajiwara Y; Ao T; Mochizuki S; Shinto E; Okamoto K; Hase K; Ueno H
    Am J Surg Pathol; 2019 Oct; 43(10):1341-1348. PubMed ID: 31318710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High fascin-1 expression in colorectal cancer identifies patients at high risk for early disease recurrence and associated mortality.
    Tampakis A; Tampaki EC; Nonni A; Kostakis ID; Posabella A; Kontzoglou K; von Flüe M; Felekouras E; Kouraklis G; Nikiteas N
    BMC Cancer; 2021 Feb; 21(1):153. PubMed ID: 33579217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer.
    Barresi V; Branca G; Ieni A; Reggiani Bonetti L; Baron L; Mondello S; Tuccari G
    Virchows Arch; 2014 Jun; 464(6):655-62. PubMed ID: 24771119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases.
    Fonseca GM; de Mello ES; Faraj SF; Kruger JAP; Coelho FF; Jeismann VB; Lupinacci RM; Cecconello I; Alves VAF; Pawlik TM; Herman P
    J Surg Oncol; 2018 Jun; 117(7):1364-1375. PubMed ID: 29448312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between ezrin protein expression and the prognosis of colorectal adenocarcinoma.
    Lin LJ; Chen LT
    Mol Med Rep; 2013 Jul; 8(1):61-6. PubMed ID: 23708420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezrin expression as a prognostic marker in colorectal adenocarcinoma.
    Patara M; Santos EM; Coudry Rde A; Soares FA; Ferreira FO; Rossi BM
    Pathol Oncol Res; 2011 Dec; 17(4):827-33. PubMed ID: 21465252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoproliferative activity in colorectal poorly differentiated clusters: Biological significance in tumor setting.
    Caramaschi S; Mangogna A; Salviato T; Ammendola S; Barresi V; Manco G; Canu PG; Zanelli G; Bonetti LR
    Ann Diagn Pathol; 2021 Aug; 53():151772. PubMed ID: 34153686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
    Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic prognostic markers in stage IIA colorectal cancer: a comparative study.
    Barresi V; Reggiani Bonetti L; Ieni A; Branca G; Tuccari G
    Scand J Gastroenterol; 2016 Mar; 51(3):314-20. PubMed ID: 26554618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.